MyDx, Inc. (OTCMKTS:MYDX) Files An 8-K Unregistered Sales of Equity Securities
Item 3.02
| Unregistered Sales of Equity Securities. |
Since November 22, 2016, MyDx, Inc. (the Company) has issued, in
reliance upon Section 4(a)(2) of the Securities Act of 1933, as
amended, 1,051,998,015 shares of common stock to conversion
notices of all convertible redeemable notes outstanding, with the
remaining principle balance equal to $46,406.21 as of March 10,
2017.
| Item 7.01 | Regulation FD Disclosure. |
Effective March 8, 2017, senior management of the Company have
begun using the materials included in Exhibit 99.1 to this report
(the Investor Presentation) in connection with presentations to
existing shareholders and potential investors of the Company. The
Investor Presentation is incorporated into this Item 7.01 by
reference and will be available on the Companys website at
www.magnegas.com.
Without limiting the generality of the foregoing, the
Forward-Looking Statements disclosure contained in the Investor
Presentation is incorporated by reference into this Item 7.01.
The information contained in this Item 7.01, including Exhibit
99.1, shall not be deemed to be filed for the purposes of Section
18 of the Exchange Act, or otherwise subject to the liabilities
of that section, and such information is not incorporated by
reference into any registration statements or other document
filed under the Securities Act of 1933, as amended or the
Exchange Act, regardless of the general incorporation language
contained in such filing, except as shall be expressly set forth
by specific reference to this filing..
| Item 8.01 | Other Events. |
On March 9, 2017, Judge Thomas Rebull of the Eleventh Judicial
Circuit of Florida issued two orders in favor of the Company.
First, an order to have a hearing on March 13, 2017 to enable the
court to adjudicate whether to grant the Companys emergency
motion to prevent Phoenix Fund Management, LLC (Phoenix) from
submitting any further issuance notices to the June 2016 $250,000
Section 3(a)(10) settlement. The Company believes Phoenix has
received all shares to which it is entitled to the Section
3(a)(10) settlement. Until the hearing, Phoenix is enjoined from
submitting any further issuance notices to the Section 3(a)(10)
settlement. Second, a temporary restraining order against Phoenix
to prevent Phoenix from submitting any further conversion notices
to a $1 million convertible note it holds. The Company believes
Phoenix has fully exercised this convertible note. The hearing on
March 13, 2017 will include further argument and further
adjudication of this issue. The Company cannot predict the
ultimate outcome of these two litigations.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits |
| Exhibit No. | Description | |
| 99.1 | Investor Presentation, dated March 8, 2017 |
About MyDx, Inc. (OTCMKTS:MYDX)
MyDx, Inc., formerly Brista Corp., is a science and technology company. The Company develops and commercializes technology and devices to measure chemicals of interest in solid, liquid or gas samples. The Company’s MyDx product is a portable chemical sensor with a hand-held analyzer and associated mobile application. Its MyDx device includes MyDx Analyzer and MyDx App. Its MyDx device with interchangeable sensors allows users to test for pesticides in food, fruits, herbs, plants and vegetables; chemicals in water, and toxins in the air. Its MyDx device uses nanotechnology and measures chemicals. MyDx device has an interface designed to communicate through Bluetooth with associated mobile application, which is downloadable on IPhone operating system (iOS), Android or Windows smartphone. The Company’s CannaDx Sensor measures the levels of chemicals with interest in Cannabis, including Cannabinoids and Terpenes and the Total Canna Profile (TCP) of the plant. MyDx, Inc. (OTCMKTS:MYDX) Recent Trading Information
MyDx, Inc. (OTCMKTS:MYDX) closed its last trading session up +0.00050 at 0.00220 with 43,852 shares trading hands.
